Acurx Pharmaceuticals, Inc. ( ACXP) - Key Metrics
ACXP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.53 | -$401.44 | -$401.44 |
| 2026Q1 | $0 | -$1.12 | -$0.94 | -$0.94 |
| 2025Q4 | $0 | -$1.05 | -$0.79 | -$0.79 |
| 2025Q3 | $0 | -$1.23 | -$1.16 | -$1.16 |
| 2025Q2 | $0 | -$1.89 | -$1.40 | -$1.40 |
ACXP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.73 |
| 2026Q1 | 0% | -0.83 |
| 2025Q4 | 0% | -0.93 |
| 2025Q3 | 0% | -0.87 |
| 2025Q2 | 0% | -1.35 |
ACXP
Price: $1.44
52 week price:
Earnings Per Share: -3.79 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 73400
Market Capitalization: 6.0 million